Smarter Not Harder
Methylene Blue Myths, Media Hype, and the Truth with Dr. Scott Sherr | SNH Podcast #121
Apr 30, 2025
Dr. Scott Sherr dives deep into the fascinating world of methylene blue, unraveling myths and media hype. Discover its historical role as an antimicrobial and its impact on mitochondrial health. He debunks the viral 'Blue Brains' headlines and discusses how this compound supports energy and detoxification in our cells. You'll also gain insights into safe dosing strategies and the truth about synthetic variants. Whether you’re curious about the science or keen on practical applications, this discussion offers clarity on a hot topic in health optimization.
33:28
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Methylene blue, initially celebrated for its antimicrobial properties, plays a pivotal role in enhancing mitochondrial function and energy metabolism.
- Recent controversies surrounding methylene blue highlight misconceptions regarding dosing and its broader impact beyond serotonin enhancement, emphasizing the need for clarity in its therapeutic use.
Deep dives
Historical Significance and Origins of Methylene Blue
Methylene blue was first synthesized in the 1870s and became the first drug registered with the FDA in 1897. Initially indicated for malaria, it was celebrated as a 'magic bullet' due to its ability to kill pathogens without harming human hosts. Over the decades, it was extensively used for various infections, including urinary tract and fungal infections, even being given in lollipop form for throat infections. Its widespread use in the early and mid-20th century waned with the introduction of antibiotics, but its historical relevance continues to shape discussions about its potential health benefits today.
